Nicolaj B Støttrup
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nicolaj B Støttrup has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Bo Falck Hansen
Diabetes Biology, Novo Nordisk A/S, Bagsværd, Denmark
1 shared publicationBo Løfgren
Department of Cardiology, Skejby Sygehus, Aarhus University Hospital, Aarhus and
1 shared publication- Hans Erik Bøtker
Aarhus University Hospital
1 shared publication Hans‐Henrik Kimose
Department of Cardiology, Skejby Sygehus, Aarhus University Hospital, Aarhus and
1 shared publicationSteen B Kristiansen
Department of Cardiology, Skejby Sygehus, Aarhus University Hospital, Aarhus and
1 shared publicationTorsten Toftegaard Nielsen
Department of Cardiology, Skejby Sygehus, Aarhus University Hospital, Aarhus and
1 shared publication
Latest Publications
- 16 October 2006
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 33 (11) , 1099-1103
l‐GLUTAMATE AND GLUTAMINE IMPROVE HAEMODYNAMIC FUNCTION AND RESTORE MYOCARDIAL GLYCOGEN CONTENT DURING POSTISCHAEMIC REPERFUSION: A RADIOACTIVE TRACER STUDY IN THE RAT ISOLATED HEART
SUMMARY: l‐Glutamate and glutamine have been suggested to have cardioprotective effects. However, the issue is controversial and the metabolic mechanisms underlying a beneficial effect are not well understood. In the present study we investigated the effects of l‐glutamate and glutamine on haemodynamic recovery, the rate of de novo glycogen synthesis and myocardial glucose uptake during postischaemic reperfusion. . Hearts from male Wistar rats (250–300 g) were divided into three groups as follows: (i) control (n = 12); (ii) l‐glutamate (n = 12); and (iii) glutamine (n = 12). Hearts were mounted in a Langendorff preparation and perfused with oxygenated Krebs’–Henseleit solution at 80 mmHg and 37C. Global ischaemia for 20 min was followed by 15 min reperfusion, during which l‐glutamate (50 mmol/L) or glutamine (20 mmol/L) were administered. Left ventricular developed pressure (LVDP), de novo synthesis of glycogen using [14C]‐glucose and myocardial glucose uptake using d‐[2‐3H]‐glucose were measured. l‐Glutamate and glutamine increased postischaemic LVDP (P < 0.01 vs control hearts for both). l‐Glutamate and glutamine increased de novo glycogen synthesis by 78% (P < 0.001) and 55% (P < 0.01), respectively. At the end of reperfusion, total myocardial glycogen content was increased by both l‐glutamate and glutamine (5.7 ± 0.3 and 6.2 ± 0.7 mmol/g wet weight, respectively; P < 0.05 and 0.01, respectively) compared with that in control hearts (3.6 ± 0.4 mmol/g wet weight). Neither l‐glutamate nor glutamine affected myocardial glucose uptake during reperfusion. . Improved postischaemic haemodynamic recovery after l‐glutamate and glutamine supplementation during reperfusion is associated with increased de novo glycogen synthesis, suggesting a favourable modulation of intracellular myocardial carbohydrate metabolism.
- 16 October 2006
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 33 (11) , 1099-1103
l‐GLUTAMATE AND GLUTAMINE IMPROVE HAEMODYNAMIC FUNCTION AND RESTORE MYOCARDIAL GLYCOGEN CONTENT DURING POSTISCHAEMIC REPERFUSION: A RADIOACTIVE TRACER STUDY IN THE RAT ISOLATED HEART
SUMMARY: l‐Glutamate and glutamine have been suggested to have cardioprotective effects. However, the issue is controversial and the metabolic mechanisms underlying a beneficial effect are not well understood. In the present study we investigated the effects of l‐glutamate and glutamine on haemodynamic recovery, the rate of de novo glycogen synthesis and myocardial glucose uptake during postischaemic reperfusion. . Hearts from male Wistar rats (250–300 g) were divided into three groups as follows: (i) control (n = 12); (ii) l‐glutamate (n = 12); and (iii) glutamine (n = 12). Hearts were mounted in a Langendorff preparation and perfused with oxygenated Krebs’–Henseleit solution at 80 mmHg and 37C. Global ischaemia for 20 min was followed by 15 min reperfusion, during which l‐glutamate (50 mmol/L) or glutamine (20 mmol/L) were administered. Left ventricular developed pressure (LVDP), de novo synthesis of glycogen using [14C]‐glucose and myocardial glucose uptake using d‐[2‐3H]‐glucose were measured. l‐Glutamate and glutamine increased postischaemic LVDP (P < 0.01 vs control hearts for both). l‐Glutamate and glutamine increased de novo glycogen synthesis by 78% (P < 0.001) and 55% (P < 0.01), respectively. At the end of reperfusion, total myocardial glycogen content was increased by both l‐glutamate and glutamine (5.7 ± 0.3 and 6.2 ± 0.7 mmol/g wet weight, respectively; P < 0.05 and 0.01, respectively) compared with that in control hearts (3.6 ± 0.4 mmol/g wet weight). Neither l‐glutamate nor glutamine affected myocardial glucose uptake during reperfusion. . Improved postischaemic haemodynamic recovery after l‐glutamate and glutamine supplementation during reperfusion is associated with increased de novo glycogen synthesis, suggesting a favourable modulation of intracellular myocardial carbohydrate metabolism.